2018 annual financial data
Adaptive Biotechnologies 2018 Operating margin
Direct answer
Operating margin was -89.39%.
Operating income was -49,756,000 USD and net income was -46,447,000 USD.
Operating cash flow was -32,259,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,663,000 USD
- Operating income
- -49,756,000 USD
- Net income
- -46,447,000 USD
- Operating cash flow
- -32,259,000 USD